Mats Brune

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50-70 year old AML patients.

Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50-70 year old AML patients.

Journal: Bone marrow transplantation

Published: April 11, 2024

NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells.

NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells.

Journal: Journal for immunotherapy of cancer

Published: August 08, 2023

Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte globulin.

Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte globulin.

Journal: Scientific reports

Published: May 22, 2023

Long-Term Immunity Against Tetanus and Diphtheria after Vaccination of Allogeneic Stem Cell Transplantation Recipients.

Long-Term Immunity Against Tetanus and Diphtheria after Vaccination of Allogeneic Stem Cell Transplantation Recipients.

Journal: Transplantation and cellular therapy

Published: October 30, 2022

Bone marrow expression of CD68/CD163 macrophages, IL-17 and FOXP3 cells in aplastic anemia and their relation to prognosis.

Bone marrow expression of CD68/CD163 macrophages, IL-17 and FOXP3 cells in aplastic anemia and their relation to prognosis.

Journal: European journal of haematology

Published: September 04, 2022

Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity.

Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity.

Journal: Blood advances

Published: December 29, 2021

Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia.

Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia.

Journal: Frontiers in immunology

Published: December 25, 2021

Reduced immunogenicity of a third COVID-19 vaccination among recipients of allogeneic hematopoietic stem cell transplantation.

Reduced immunogenicity of a third COVID-19 vaccination among recipients of allogeneic hematopoietic stem cell transplantation.

Journal: Haematologica

Published: December 09, 2021

Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia.

Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia.

Journal: Frontiers in immunology

Published: October 15, 2021

Late follow-up of genital and ophthalmologic chronic graft-vs-host disease in females after allogeneic stem cell transplantation.

Late follow-up of genital and ophthalmologic chronic graft-vs-host disease in females after allogeneic stem cell transplantation.

Journal: Acta obstetricia et gynecologica Scandinavica

Published: May 28, 2021

Vaccination against tick-borne encephalitis (TBE) after autologous and allogeneic stem cell transplantation.

Vaccination against tick-borne encephalitis (TBE) after autologous and allogeneic stem cell transplantation.

Journal: Vaccine

Published: October 07, 2020

Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period.

Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period.

Journal: Blood

Published: September 14, 2019

Showing 1-12 of 39

Last Updated: 09/26/2026